|
A multitude of new active agents generated by chemical and biotechnological screening methods have set new benchmarks as to the requirements to modern drug delivery systems. Understanding both, the new compounds and selecting the most suitable drug carrier, is one of MCS' core assets.
We welcome to work on almost any NCEs, NBEs, marketed drugs or generic compounds falling under the following classification:
|